Login to Your Account

31st Annual J.P. Morgan Healthcare Conference

Biosimilar Pioneers Play Their Strategy Cards Close to Vest

By Lynn Yoffee
Executive Editor

Thursday, January 10, 2013

With an established reputation for its generic drugs, Mumbai, India-based Lupin Ltd. has expanded into biosimilars in its quest to become a global biopharma powerhouse. But like the foggy view from the 32nd-floor penthouse location of the Asia track at the J.P. Morgan Healthcare Conference Wednesday morning, the firm's chief financial officer provided limited insight into the company's biosimilars strategy despite audience questions.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription